Page 21 - Loncode Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Loncode institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Loncode Institute Today - Breaking & Trending Today

Neogene Therapeutics Announces Ton Schumacher, Ph.D., Company Co-Founder, Awarded 2021 Jeantet-Collen Prize for Translational Medicine


Press release content from Business Wire. The AP news staff was not involved in its creation.
Neogene Therapeutics Announces Ton Schumacher, Ph.D., Company Co-Founder, Awarded 2021 Jeantet-Collen Prize for Translational Medicine
January 26, 2021 GMT
NEW YORK & AMSTERDAM (BUSINESS WIRE) Jan 26, 2021
Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced that the company’s co-founder, Board member and Chairman of its Scientific Advisory Board, Ton Schumacher, Ph.D., has been awarded the 2021 Jeantet-Collen Prize for Translational Medicine. Awarded each year by the Louis-Jeantet Foundation to leading-edge researchers who are active in the member states of the Council of Europe, the prize is intended to foster scientific excellence and encourage the continuation of innovative research projects. ....

United States , Noord Holland , Carsten Linnemann , Williamb Coley , Sheryl Seapy , Council Of Europe , Meyenburg Cancer Research Award , Queen Wilhelmina Cancer Research Award , Neogene Therapeutics Inc , Loncode Institute , Louis Jeantet Foundation , Netherlands Cancer Institute , Stevin Award Of The Dutch Research Council , Scientific Advisory Board , Ton Schumacher , Collen Prize , Chief Executive Officer , Translational Medicine , Principal Investigator , Leiden University Medical , Neon Therapeutics , Chief Scientific Officer , Kite Pharma , Amsterdam Inventor Award , Stevin Award , Dutch Research ,

Neogene Therapeutics, Inc.: Neogene Therapeutics Announces Ton Schumacher, Ph.D., Company Co-Founder, Awarded 2021 Jeantet-Collen Prize for Translational Medicine


(1)
Renowned immunologist and T cell engineering expert awarded distinguished prize for conducting fundamental translational research of substantial significance for medicine
Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced that the company s co-founder, Board member and Chairman of its Scientific Advisory Board, Ton Schumacher, Ph.D., has been awarded the 2021 Jeantet-Collen Prize for Translational Medicine. Awarded each year by the Louis-Jeantet Foundation to leading-edge researchers who are active in the member states of the Council of Europe, the prize is intended to foster scientific excellence and encourage the continuation of innovative research projects. ....

Noord Holland , Carsten Linnemann , Williamb Coley , Kostenloser Wertpapierhandel , Sheryl Seapy , Council Of Europe , Queen Wilhelmina Cancer Research Award , Meyenburg Cancer Research Award , Neogene Therapeutics Inc , Loncode Institute , Louis Jeantet Foundation , Netherlands Cancer Institute , Stevin Award Of The Dutch Research Council , Scientific Advisory Board , Ton Schumacher , Collen Prize , Chief Executive Officer , Translational Medicine , Principal Investigator , Leiden University Medical , Neon Therapeutics , Chief Scientific Officer , Kite Pharma , Amsterdam Inventor Award , Stevin Award , Dutch Research ,

Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment


Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment
Company Prepares for Commercialization of Revolutionary In-Office Therapy
Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B financing. The round was led by new investor LSP, from its LSP HEF-2 fund, and co-led by Atlantic Bridge, investing from its Growth Fund IV. Fountain Healthcare Partners also participated as a returning investor with strong participation in the round.
The financing will support the expansion of the company s clinical and commercial operations as it prepares for U.S. Food and Drug Administration (FDA) clearance and U.S. commercialization of its proprietary NEUROMARK Rhinitis Neurolysis Therapy, an innovative in-office treatment for chronic rhinitis. ....

United States , Baden Wuberg , Noord Holland , Gerry Maguire , Kostenloser Wertpapierhandel , Jessica Stebing , Zealand Pharma , Company Prepares For Commercialization Of Revolutionary , Loncode Institute , Growth Fund , Office Therapy , Drug Administration , Dutch Venture Initiative , Company Prepares , Revolutionary In Office Therapy , Atlantic Bridge , Healthcare Partners , Neurolysis Therapy , Rhinitis Neurolysis Therapy , Neurent Medical , Co Founder Brian , Drew Burdon , Investment Manager , General Partner , Medi Cal , ஒன்றுபட்டது மாநிலங்களில் ,